Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

AUROBINDO PHARMA

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 27

FDA approve OMEPRAZOLE; SODIUM BICARBONATE

Comment Full text

ALEMBIC

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 30

FDA approve DICLOFENAC SODIUM

Comment Full text

SENORES PHARMS

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 32

FDA approve KETOROLAC TROMETHAMINE

Comment Full text

MARKSANS PHARMA

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 31

FDA approve LORATADINE

Comment Full text

AUROBINDO PHARMA

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 30

FDA approve MOMETASONE FUROATE

Comment Full text

STERISCIENCE

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 33

FDA approve SUMATRIPTAN SUCCINATE

Comment Full text

NEXUS

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 32

FDA approve METHYLENE BLUE

Comment Full text

USWM

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 27

FDA approve DANTROLENE SODIUM

Comment Full text

SCIEGEN PHARMS INC

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 32

FDA approve ESOMEPRAZOLE MAGNESIUM; NAPROXEN

Comment Full text

YICHANG HUMANWELL

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 34

FDA approve IBUPROFEN

Comment Full text
  • Previous
  • 135
  • 136
  • 137
  • 138
  • 139
  • Next

Search

News categories

  • Technical Exchange News(9391)
  • Event(407)
  • SEC News(153945)
  • FDA Approval(8781)
  • Company Report(721)
  • Business News(104963)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin